Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $89.8100 (0.55%) ($87.7100 - $89.9800) on Thu. Jan. 30, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.34% (three month average) | RSI | 34 | Latest Price | $89.8100(0.55%) | Stocks Behave Similarly | Similar Stock List | Weekly Trend | LGND declines -2% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Normal for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) IBB(60%) IWO(58%) IWC(55%) XBI(55%) IWM(53%) | Factors Impacting LGND price | LGND will decline at least -1.17% in a week (0% probabilities). VIXM(-33%) VXX(-20%) TLT(-14%) UUP(-5%) SHY(-5%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.17% (StdDev 2.34%) | Hourly BBV | 0 () | Intraday Trend | 1.5% | | | |
|
1 - 5 Day Possible Target | $80.8(-10.03%) | Resistance Level | $92.75 | 5 Day Moving Average | $88.45(1.54%) | 10 Day Moving Average | $89.54(0.3%) | 20 Day Moving Average | $92.75(-3.17%) | To recent high | -20.5% | To recent low | 3.8% | Market Cap | $1.443b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |